Changes in Pituitary Hormones Serum Levels in Bromocryptine-Treated Parkinsonian Patients

1977 
In the course of a clinical trial with 2α-bromoergocryptine in Parkinson’s disease, the serum levels of several pituitary hormones have been studied in the assumption that the drug active on nigro-striatal dopaminergic system might also interfere with hypothalamus-protuberantial neurotransmission, and have effects on the function of the pituitary. No changes in serum levels of FSH, LH, STH and TSH were detected for every dose of the drug employed. Only prolactin serum levels diminished since the beginning of the treatment, the decrease being significant (p
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    9
    Citations
    NaN
    KQI
    []